Back to results
US 10,883,980 B2Granted
Methods and compositions for inhibiting hepatitis E virus
AssigneeThe Trustees of Princeton University
InventorsAlexander Ploss, Qiang Ding
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of inhibiting hepatitis E virus (HEV) release from a cell that is infected with an HEV, and a method of treating a HEV infection in a subject in need thereof. The present invention also provides a method of identifying agent that inhibits HEV infectivity using a transcomplementation system.
Claims11
A method of identifying an agent that inhibits hepatitis E virus (HEV) infectivity, comprising:
- a) introducing into a cell culture 1) a nucleic acid that comprises an HEV open reading frame 2 (ORF2) nucleotide sequence, 2) a nucleic acid that comprises an HEV ORF3 nucleotide sequence, and 3) a nucleic acid that i) comprises a reporter gene and an HEV ORF1 nucleotide sequence and ii) lacks HEV ORF2 and ORF3 nucleotide sequences;
- b) contacting the cell culture in step a) with an agent to be tested for anti-HEV activity;
- c) harvesting the cell culture media from the cell culture that has been contacted with the agent;
- d) combining the harvested media with a naïve cell culture;
- e) measuring a level of activity of the reporter gene in the naïve cell culture;
- and
- f) comparing the level of reporter activity in the naïve cell culture measured in step e) to a reference activity level,
- wherein a decrease in measured activity level as compared to the reference activity level indicates that the agent inhibits HEV infectivity.
5 more elements
Dependencies are inferred from the claim text.